DuPont Merck Coumadin May Not Require Prior Authorization In Ohio
Executive Summary
DuPont Merck's Coumadin (warfarin) may be exempted from Ohio's Medicaid brand name prior authorization requirement even after another generic equivalent becomes available.
You may also be interested in...
Rockefeller Generic Rx Bill Would Penalize Brands For Failed Patent Defense
Generic drug legislation floated by Sen. Jay Rockefeller (D-W.Va.) would create a drug reimbursement fund to compensate parties denied access to generic drugs due to litigation
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011